Filing Details
- Accession Number:
- 0001127602-14-024045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-29 16:01:28
- Reporting Period:
- 2014-07-28
- Filing Date:
- 2014-07-29
- Accepted Time:
- 2014-07-29 16:01:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1379970 | C Steven Gilman | 65 Hayden Avenue Lexington MA 02421 | Evp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-28 | 34,100 | $25.23 | 61,698 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-07-28 | 6,525 | $25.23 | 68,223 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-28 | 34,100 | $61.40 | 34,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-07-28 | 6,525 | $62.44 | 27,598 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2014-07-28 | 34,100 | $0.00 | 34,100 | $25.23 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2014-07-28 | 6,525 | $0.00 | 6,525 | $25.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,900 | 2011-01-15 | 2020-10-15 | No | 4 | M | Direct |
| 9,375 | 2011-01-15 | 2020-10-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,851 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $61.03 to $62.02. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $62.04 to $62.93. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 6.25% quarterly over a four-year period.
Billionaire Hedge Funds
